WO2013002802A1 - Ready to drink beverage composition - Google Patents

Ready to drink beverage composition Download PDF

Info

Publication number
WO2013002802A1
WO2013002802A1 PCT/US2011/042609 US2011042609W WO2013002802A1 WO 2013002802 A1 WO2013002802 A1 WO 2013002802A1 US 2011042609 W US2011042609 W US 2011042609W WO 2013002802 A1 WO2013002802 A1 WO 2013002802A1
Authority
WO
WIPO (PCT)
Prior art keywords
approximately
isoleucine
valine
leucine
arginine
Prior art date
Application number
PCT/US2011/042609
Other languages
French (fr)
Inventor
Jeffrey Liebrecht
Cydney WHITMOYER
Original Assignee
Taylor, Matthew
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taylor, Matthew filed Critical Taylor, Matthew
Priority to PCT/US2011/042609 priority Critical patent/WO2013002802A1/en
Publication of WO2013002802A1 publication Critical patent/WO2013002802A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • This invention relates to a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, in particular, the invention relates to a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth.
  • HGH human growth hormone
  • HGH The primary purpose of HGH is that of stimulating growth, cell repair, and cell regeneration. Once the growth period is over, its primary function becomes that of cell regeneration and repair, helping to regenerate skin, bones, heart, lungs, liver, and kidneys to their former youthful cell levels. HGH appears to selectively reduce the fat around the abdomen, hips, waist and thighs while at the same time increasing muscle mass.
  • Muscle requires a large array of nutrients, including amino acids (which are derived from protein) for growth. Such nutrients have been supplied by ingesting foods and supplements that provide the necessary amounts of protein (the source of amino acids), calories, and other nutrients.
  • Powders that contain appropriate amino acids are available in cans and jars that come with scoopers for measuring dosages into a glass to which water or other beverage is to be added. Some problems with powders are consuming the powder dry is very difficult, and many of the powders taste bad, even if mixed with water; if mixed with juice or milk, the fructose or lactose of the juice/milk raises blood glucose and insulin levels. Such products are, however, generally unpalatable and do not, in fact, satisfy the body completely by replenishing all the essential constituents which are lost.
  • One object of the present invention is to provide a new method of stimulating production of HGH for natural muscle growth stimulation, in the form of a tasty, convenient ready-to-drink beverage.
  • HGH Releasing Factor The provision of an agonist/inhibition blockade to HGH Releasing Factor is the premise of the use of L-Arginine at basal metabolic levels. Until now, these were only available in a barely palatable powder form because of technical and biochemical difficulty in creating a product that is bioavailable. To stimulate HGH production in this manner goes against the teaching of the prior art because it was believed not to be possible to combine the necessary amino acids with any food for the reasons stated above.
  • the delivery system of the present invention therefore combines the preferred amino acid dosages with ready-to- drink beverages that taste good and are convenient, as opposed to the prior art of powders and pills.
  • the present invention provides a multi-electrolyte composition including water, fructose, inulin, and flavoring to provide a more palatable drink with a better balance of electrolytes and HGH.
  • This isotonic energy drink also includes critical vitamins and minerals as important nutrients for muscle growth and optimum performance.
  • the invention comprises a ready to drink beverage product for direct increase of human growth hormone (HGH) by using HGH precursors to stimulate natural production.
  • HGH human growth hormone
  • Simple sugars and critical vitamins and minerals are blended in water to provide an electrolyte solution for daily consumption to stimulate muscle growth.
  • a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, containing optimum quantities of sugars, salts, and minerals, including essential amino acids is disclosed.
  • a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth is described.
  • L-Arginine is known to be a human growth hormone precursor that stimulates the pituitary gland, which controls body growth.
  • Other essential amino acids contained in the beverage composition of the present invention are Isoleucine, Leucine, and Valine.
  • the beverage is consumed on a daily basis, preferably at night before sleeping. While the body is at rest, the HGH works to stimulate muscle growth naturally.
  • the beverage composition of the present invention works as a dietary supplement by assisting the body's own ability to secrete HGH naturally in a manner that is safe and effective. While L-Arginine is useful in stimulating muscle growth, when taken alone on an empty stomach it has some disadvantages. First, the L- Arginine has an extremely unpleasant taste that makes the oral administration of large dosages difficult and sometimes impossible.
  • the formulation has an acid pH, i.e. less than 7.0.
  • the preferred pH is less than 4.0.
  • the pH is preferably controlled by the presence in the L-Arginine composition of a pharmaceutically acceptable acid in an amount that results in a pH of less than 4 when the composition is administered orally.
  • a pharmaceutically acceptable acid is maltic acid, but the invention is not limited to this acid and other suitable pharmaceutically acceptable acids may be employed.
  • a ready to drink beverage having a liquid form HGH pre-cursor is mixed together using water, sweeteners, maltic acid, flavoring, and a blend of vitamins and minerals.
  • the combination of vitamins and minerals includes Pantothenic Acid, Boron, Chromium, Copper, and Choline. Additional ingredients include L-Arginine, L-Isoleucine, L-Leucine, and L- Valine.
  • a powder premixture comprising the following composition:
  • Pantothenic Acid (as D-Calcium Pantothenate, USP) 2 - 8 mg
  • Chromium (as Chromium Chloride (6H 2 0), USP) 10 - 15 meg
  • the premixture contains:
  • Pantothenic Acid (as D-Calcium Pantothenate, USP) approximately 5 mg
  • Chromium (as Chromium Chloride (6H 2 0), USP) approximately 12 meg
  • the beverage is prepared by agitating a quantity of reverse osmosis water with a quantity of premixture of the vitamins and minerals. A sufficient amount of L-
  • Arginine is added and mixed thoroughly until dissolved.
  • a sufficient amount of Fruitafit Inulin HD and Fructose are added and mixed thoroughly until dissolved.
  • a sufficient amount of Sucralose and Acesulfame-K are added and mixed thoroughly until dissolved. Once the ingredients are thoroughly combined, flavoring and natural colors are added. Next, a sufficient quantity of malic acid is added to adjust the pH to less than 4.0.
  • the solution is heated to approximately 185°F for about 10-30 seconds. While still hot, the solution is placed in bottles, sealed, and quick cooled, by plunging a sealed bottle in an ice bath.
  • Each 8-ounce serving comprises the following approximate constituents:
  • Sweetener-Splenda MNP approximately 0.064 g
  • Acesulfame-K (Potassium)-Sweetener RCC approximately 0.027 g
  • the beverage is blended to provide the following approximate components:
  • Each 8-ounce serving contains the following approximate nutrients per serving:

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A dietary supplement that can be used by athletes and bodybuilders for restoring human growth hormones using liquid form HGH precursors. The composition includes fluids containing water, sugar including the carbohydrates, fructose and maltodextrin, and electrolytes chromium, copper, potassium, magnesium, sodium, and malic acid. The composition also includes selected amino acids in liquid form such as L-Leucine, L-Isoleucine, L-Valine and L- Arginine.

Description

Ready to Drink Beverage Composition
Technical Field
This invention relates to a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, in particular, the invention relates to a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth.
Background Art
There are presently a substantial number of electrolyte drinks on the market that are alleged to replenish essential electrolytes and water lost from the body during physical activity. Physical exercise can be distinguished in different categories i.e. those requiring strength, strength and speed, or endurance. In practice, this can be heavy work, muscle activity under severe conditions (e.g. high temperature, high altitude), leisure sports, or athletic performance.
Athletes who participate in sports at any level, amateur or professional, strive to bring their bodies to a physical state that is optimum for the sport or activity of interest. One factor that enables athletes to participate effectively is a high degree of development of the aerobic capacity and/or strength of skeletal muscles. The inherent problem is a built-in failure in stimulus of production and release of human growth hormone (HGH). Human growth hormone (HGH) is an endocrine hormone produced by the pituitary gland. Upon its release from the pituitary gland, HGH is converted by the liver and other tissues. The natural production of HGH incrementally decreases in the normal human being after approximately 23 years of age. Its production peaks during adolescence and diminishes with age. The primary purpose of HGH is that of stimulating growth, cell repair, and cell regeneration. Once the growth period is over, its primary function becomes that of cell regeneration and repair, helping to regenerate skin, bones, heart, lungs, liver, and kidneys to their former youthful cell levels. HGH appears to selectively reduce the fat around the abdomen, hips, waist and thighs while at the same time increasing muscle mass.
The desire to attain, in a rapid manner, the maximum degree of skeletal muscle adaptation to exercise has led some athletes to resort to the use of drugs. Such drugs, particularly steroids, are known to "force" muscle growth to degrees greater than can be achieved by exercise and diet alone. The use of such drugs is both illegal and dangerous. The side effects of steroids are dangerous and unacceptable. Indeed, all professional sports leagues, as well as collegiate athletics, have a long list of potentially performance enhancing substances, many of which may be over-the- counter products, the use of any of which is banned. It is therefore important to provide a natural growth stimulus that does not contain any of the banned ingredients.
Muscle requires a large array of nutrients, including amino acids (which are derived from protein) for growth. Such nutrients have been supplied by ingesting foods and supplements that provide the necessary amounts of protein (the source of amino acids), calories, and other nutrients.
Powders that contain appropriate amino acids are available in cans and jars that come with scoopers for measuring dosages into a glass to which water or other beverage is to be added. Some problems with powders are consuming the powder dry is very difficult, and many of the powders taste bad, even if mixed with water; if mixed with juice or milk, the fructose or lactose of the juice/milk raises blood glucose and insulin levels. Such products are, however, generally unpalatable and do not, in fact, satisfy the body completely by replenishing all the essential constituents which are lost. One object of the present invention, then, is to provide a new method of stimulating production of HGH for natural muscle growth stimulation, in the form of a tasty, convenient ready-to-drink beverage. The provision of an agonist/inhibition blockade to HGH Releasing Factor is the premise of the use of L-Arginine at basal metabolic levels. Until now, these were only available in a barely palatable powder form because of technical and biochemical difficulty in creating a product that is bioavailable. To stimulate HGH production in this manner goes against the teaching of the prior art because it was believed not to be possible to combine the necessary amino acids with any food for the reasons stated above. The delivery system of the present invention therefore combines the preferred amino acid dosages with ready-to- drink beverages that taste good and are convenient, as opposed to the prior art of powders and pills.
The present invention provides a multi-electrolyte composition including water, fructose, inulin, and flavoring to provide a more palatable drink with a better balance of electrolytes and HGH. This isotonic energy drink also includes critical vitamins and minerals as important nutrients for muscle growth and optimum performance.
Disclosure of Invention
The invention comprises a ready to drink beverage product for direct increase of human growth hormone (HGH) by using HGH precursors to stimulate natural production. Simple sugars and critical vitamins and minerals are blended in water to provide an electrolyte solution for daily consumption to stimulate muscle growth.
It is, therefore, an object of the present invention to enable beverage compositions for use in growth stimulation that avoids the disadvantages of the prior art. It is another object of the present invention to enable a method for preparing such beverage compositions.
It is yet another object of the present invention to enable a beverage composition that stimulates production of HGH that typically diminishes with age.
It is more specifically an object of the invention to provide such a beverage composition that is pleasant tasting.
It is another object of the invention to provide a beverage composition having electrolytes in correct physiological quantities to increase the efficiency of the body to utilize sugars and improve muscular activities.
It is still a further object of the present invention to enable a beverage composition that does not contain ingredients that have been banned from use by professional athletes.
In accordance with the above and other objects, a nutritional dietary supplement drink containing a liquid form human growth hormone pre-cursor, containing optimum quantities of sugars, salts, and minerals, including essential amino acids is disclosed. In particular, a drink for consumption on a daily basis by athletes of all skill levels to aid muscle growth is described.
The various features of novelty that characterize the invention will be pointed out with particularity in the claims of this application.
Best Mode(s) for Carrying Out the Invention
The invention summarized above may be better understood by referring to the following description. This description of an embodiment, set out below to enable one to build and use an implementation of the invention, is not intended to limit the enumerated claims, but to serve as a particular example thereof. Those skilled in the art should appreciate that they may readily use the conception and specific embodiments disclosed as a basis for modifying or designing other methods and systems for carrying out the same purposes of the present invention. Those skilled in the art should also realize that such equivalent assemblies do not depart from the spirit and scope of the invention in its broadest form.
L-Arginine is known to be a human growth hormone precursor that stimulates the pituitary gland, which controls body growth. Other essential amino acids contained in the beverage composition of the present invention are Isoleucine, Leucine, and Valine. In a preferred embodiment, the beverage is consumed on a daily basis, preferably at night before sleeping. While the body is at rest, the HGH works to stimulate muscle growth naturally.
The beverage composition of the present invention works as a dietary supplement by assisting the body's own ability to secrete HGH naturally in a manner that is safe and effective. While L-Arginine is useful in stimulating muscle growth, when taken alone on an empty stomach it has some disadvantages. First, the L- Arginine has an extremely unpleasant taste that makes the oral administration of large dosages difficult and sometimes impossible.
In order to overcome these disadvantages, it is possible to administer high dosages of L-Arginine if the formulation has an acid pH, i.e. less than 7.0. The preferred pH is less than 4.0. By controlling the pH in this way, it has been found that the L-Arginine is more readily accepted by the gastrointestinal tract, that there is minimum depletion of normal body chemicals and is pleasant to taste. Moreover, the stability of the composition is improved as a result of ensuring that the composition has an acid pH.
The pH is preferably controlled by the presence in the L-Arginine composition of a pharmaceutically acceptable acid in an amount that results in a pH of less than 4 when the composition is administered orally. A preferred acid is maltic acid, but the invention is not limited to this acid and other suitable pharmaceutically acceptable acids may be employed.
In a first embodiment, a ready to drink beverage having a liquid form HGH pre-cursor is mixed together using water, sweeteners, maltic acid, flavoring, and a blend of vitamins and minerals. The combination of vitamins and minerals includes Pantothenic Acid, Boron, Chromium, Copper, and Choline. Additional ingredients include L-Arginine, L-Isoleucine, L-Leucine, and L- Valine.
In a preferred embodiment, a powder premixture is formulated comprising the following composition:
Pantothenic Acid (as D-Calcium Pantothenate, USP) 2 - 8 mg
Boron (as Sodium Borate, USP) 0.5 - 2 mg
Chromium (as Chromium Chloride (6H20), USP) 10 - 15 meg
Copper (as Copper Sulfate) 0.1 - 0.4 mg
L-Isoleucine (USP) 15 - - 45 mg
L-Leucine (USP) 30 - - 75 mg
L- Valine (USP) 15 - - 45 mg
Choline (as Choline Bitartrate, FCC) 15 - - 45 mg
Maltodextrin (as Maltrin M-100) Q.S.
Approximately 225 mg of the premixture is used for an 8 fluid ounce serving.
Preferably, the premixture contains:
Pantothenic Acid (as D-Calcium Pantothenate, USP) approximately 5 mg
Boron (as Sodium Borate, USP) approximately 1 mg
Chromium (as Chromium Chloride (6H20), USP) approximately 12 meg
Copper (as Copper Sulfate) approximately 0.2 mg
L-Isoleucine (USP) approximately 25 mg
L-Leucine (USP) approximately 50 mg
L- Valine (USP) approximately 25 mg
Choline (as Choline Bitartrate, FCC) approximately 25 mg Maltodextrin (as Maltrin M-100) Q.S.
The beverage is prepared by agitating a quantity of reverse osmosis water with a quantity of premixture of the vitamins and minerals. A sufficient amount of L-
Arginine is added and mixed thoroughly until dissolved. A sufficient amount of Fruitafit Inulin HD and Fructose are added and mixed thoroughly until dissolved. A sufficient amount of Sucralose and Acesulfame-K are added and mixed thoroughly until dissolved. Once the ingredients are thoroughly combined, flavoring and natural colors are added. Next, a sufficient quantity of malic acid is added to adjust the pH to less than 4.0.
The solution is heated to approximately 185°F for about 10-30 seconds. While still hot, the solution is placed in bottles, sealed, and quick cooled, by plunging a sealed bottle in an ice bath.
Each 8-ounce serving comprises the following approximate constituents:
Oligofructose-Raftilose P95-Pwd RHF approximately 2.95 g
Krystar Crystalline Fructose-Sweetener STC approximately 5.79 g
Sweetener-Splenda MNP approximately 0.064 g
Acesulfame-K (Potassium)-Sweetener RCC approximately 0.027 g
Premixture approximately 225 mg
Natural Flavor (OSF 1.01) approximately 2.72 g
Maltic Acid- Anhydrous (Acidulent) HRC approximately 6.5 g
Water approximately 581.7 g
L-Arginine approximately 3 g
The beverage is blended to provide the following approximate components:
Figure imgf000008_0001
Each 8-ounce serving contains the following approximate nutrients per serving:
Calories 15.00
Protein 0.00 e
Carbohydrates 3.65 e
Dietarv Fiber 1.2 e
Fat -total 0.00 e
Saturated Fat O e
% calories from fat 0 %
% calories from carbs 98 %

Claims

Claims What is claimed is:
1. A liquid beverage product containing liquid form human growth hormone pre-cursors for consumption by humans as a nutritional dietary supplement drink for restoring human growth hormone, said beverage product comprising optimum quantities of:
(A) pantothenic acid;
(B) boron;
(C) chromium;
(D) copper;
(E) isoleucine, where said isoleucine is in the form of L- Isoleucine; (F) leucine, where said leucine is in the form of L- Leucine; (G) valine, where said valine is in the form of L- Valine;
(H) choline;
(I) arginine, where said arginine is in the form of L-Arginine; and (J) reverse osmosis water in a quantity at least sufficient for providing a solution wherein components (A) to (I) are substantially dissolved, wherein said solution further comprises natural flavoring and sufficient maltic acid to reduce pH of the solution to less than 4, and which solution is ready for consumption by drinking.
2. The beverage product of Claim 1, wherein the ingredients consist of:
(A) about 2 mg to about 8 mg of pantothenic acid;
(B) about 0.5 mg to about 2 mg of boron;
(C) about 10 meg to about 15 meg of chromium;
(D) about 0.1 mg to about 0.4 mg of copper;
(E) about 15 mg to about 45 mg of L-Isoleucine; (F) about 30 mg to about 75 mg of L-Leucine;
(G) about 15 mg to about 45 mg of L- Valine;
(H) about 15 mg to about 45 mg of choline; and
(I) about 2000 mg of L-Arginine.
3. The beverage product of Claim 1 , wherein the ingredients consist of:
(A) approximately 5 mg of pantothenic acid;
(B) approximately 1 mg of boron;
(C) approximately 12 meg of chromium;
(D) approximately 0.2 mg of copper;
(E) approximately 25 mg of L-Isoleucine;
(F) approximately 50 mg of L-Leucine;
(G) approximately 25 mg of L- Valine;
(H) approximately 25 mg of choline; and
(I) approximately 2000 mg of L-Arginine.
4. A method of preparing a liquid beverage product for consumption by humans for restoring human growth hormone, said method comprising the steps of:
(A) stirring a quantity of reverse osmosis water;
(B) adding a sufficient quantity of a natural sweetener and dissolving such sweetener in the water;
(C) adding a sufficient quantity of a premixture and dissolving such premixture in the water;
(D) adding a sufficient quantity of L-Arginine;
(E) after thoroughly dissolving all ingredients in the water, adding flavoring and debittering agents and a sufficient quantity of malic acid to adjust the pH to less than 4.0.
5. The method of Claim 4, in which such natural sweeteners are selected from the group consisting of:
(A) Inulin;
(B) Fructose;
(C) Sucralose; and
(D) Acesulfame-K.
6. The method of Claim 4, in which such premixture comprises:
(A) about 2 mg to about 8 mg of pantothenic acid;
(B) about 0.5 mg to about 2 mg of boron;
(C) about 10 meg to about 15 meg of chromium;
(D) about 0.1 mg to about 0.4 mg of copper;
(E) about 15 mg to about 45 mg of L-Isoleucine;
(F) about 30 mg to about 75 mg of L-Leucine;
(G) about 15 mg to about 45 mg of L- Valine;
(H) about 15 mg to about 45 mg of choline.
7. The method of Claim 4, further comprising the steps of:
(I) sterilizing such solution; and
(J) dividing such solution into smaller quantities for bottling.
8. A method of supplementing the diet of a human to stimulate muscle growth comprising administering leucine, isoleucine, valine and arginine, wherein the isoleucine is in the form of L-Isoleucine, the leucine is in the form of L-Leucine, the valine is in the form of L- Valine, and the arginine is in the form of L- Arginine, in combination with pantothenic acid, sodium, potassium, copper, chromium, chorine, and boron on a daily basis.
9. The method of Claim 8 wherein the arginine is administered in a dosage of approximately 2000 mg.
10. The method of Claim 8 wherein the L-Leucine is administered in a dosage of about 30 mg to about 75 mg.
11. The method of Claim 8 wherein the L-Isoleucine is administered in a dosage of about 15 mg to about 45 mg.
12. The method of Claim 8 wherein the L-Valine is administered in a dosage of about 15 mg to about 45 mg.
13. The method of Claim 8 wherein the L-Leucine is administered in a dosage of approximately 50 mg.
14. The method of Claim 8 wherein the L-Isoleucine is administered in a dosage approximately 25 mg.
15. The method of Claim 8 wherein the L- Valine is administered in a dosage of approximately 25 mg.
PCT/US2011/042609 2011-06-30 2011-06-30 Ready to drink beverage composition WO2013002802A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US2011/042609 WO2013002802A1 (en) 2011-06-30 2011-06-30 Ready to drink beverage composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/042609 WO2013002802A1 (en) 2011-06-30 2011-06-30 Ready to drink beverage composition

Publications (1)

Publication Number Publication Date
WO2013002802A1 true WO2013002802A1 (en) 2013-01-03

Family

ID=47424455

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/042609 WO2013002802A1 (en) 2011-06-30 2011-06-30 Ready to drink beverage composition

Country Status (1)

Country Link
WO (1) WO2013002802A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932647B1 (en) * 2013-08-11 2015-01-13 Matthew F. Taylor, Jr. Functional beverage composition
US20210353705A1 (en) * 2018-10-04 2021-11-18 India Globalization Capital, Inc. Method and composition for relieving fatigue and restoring energy

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866877B2 (en) * 1998-12-29 2005-03-15 Mac Farms, Inc. Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage
US20050064013A1 (en) * 2002-10-11 2005-03-24 Jeffrey Liebrech Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
WO2006052231A1 (en) * 2004-11-03 2006-05-18 Taylor, Matthew, F. Ready to drink beverage composition
US20060134300A1 (en) * 2004-12-20 2006-06-22 Newman Arnold L Nutritional supplement for caffeine-containing beverages
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US20100015288A1 (en) * 2006-12-27 2010-01-21 Kao Corporation Packed drink

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866877B2 (en) * 1998-12-29 2005-03-15 Mac Farms, Inc. Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage
US20050064013A1 (en) * 2002-10-11 2005-03-24 Jeffrey Liebrech Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
WO2006052231A1 (en) * 2004-11-03 2006-05-18 Taylor, Matthew, F. Ready to drink beverage composition
US20060134300A1 (en) * 2004-12-20 2006-06-22 Newman Arnold L Nutritional supplement for caffeine-containing beverages
US20100015288A1 (en) * 2006-12-27 2010-01-21 Kao Corporation Packed drink

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932647B1 (en) * 2013-08-11 2015-01-13 Matthew F. Taylor, Jr. Functional beverage composition
US20210353705A1 (en) * 2018-10-04 2021-11-18 India Globalization Capital, Inc. Method and composition for relieving fatigue and restoring energy

Similar Documents

Publication Publication Date Title
US6039987A (en) Physical endurance drink and method of preventing cramping caused by strenuous bodily activity
Campbell Synergistic use of higher-protein diets or nutritional supplements with resistance training to counter sarcopenia
TW200410680A (en) Nutritiona compositions
CN103458891A (en) Nutritional composition
US20050064070A1 (en) Beverage compositions for use in rehydration and nutrition during athletic exercise and methods of making same
CN108778269A (en) Include the composition of Nicotinic Acid Amide riboside and urolithin
CN104522675A (en) Endurance type weariness resistant composition and preparation method thereof
US20060172016A1 (en) Muscle cramp reliever
CN109953231A (en) L-carnitine beverage and preparation method thereof
ES2792829T3 (en) Functional and stable protein mixture for food compositions intended for people who need an improvement and maintenance of their physical condition
US20030104107A1 (en) Energy drink formula and method
Sanz et al. An overview on essential amino acids and branched chain amino acids
CN102415447A (en) Calcium supplement electuary for infants and preparation process thereof
US20070248648A1 (en) High protein, fatigue reducing powder
US20150044302A1 (en) Compositions and methods for promoting appetite suppression using alkali metals
WO2013002802A1 (en) Ready to drink beverage composition
US20200054045A1 (en) All-Natural Drink Composition for Synthesizing and Regenerating Adenosine Triphosphate (ATP) in Muscle Cells and Neurons, Repairing Exercise-Induced Muscle Fiber Damage, Repletion of Glycogen Stores in the Muscle and Liver, Enhancing Blood Flow to Tissue during Intense Exercise, and Preventing and Reducing Oxidative Damage to Tissues during Exercise with Minimal Gastrointestinal Disturbances
US20050064013A1 (en) Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
WO2006052231A1 (en) Ready to drink beverage composition
JPS61215323A (en) Nutrient food and drink
US8932647B1 (en) Functional beverage composition
JPH0549444A (en) Food for improvement of stamina
US20190365707A1 (en) Methods of ameliorating post-dialysis washout and nutritional supplements for use in such methods
ES2302396B1 (en) FUNCTIONAL FOOD BASED ON A LIQUID FERMENTED LACQUER PRODUCT AND CONJUGATED LYNOLEIC ACID.
US20210038670A1 (en) Composition and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11868506

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A, DATED 11-03-2014)

122 Ep: pct application non-entry in european phase

Ref document number: 11868506

Country of ref document: EP

Kind code of ref document: A1